Synthetic Lethality of Wnt Pathway Activation and Asparaginase in Drug-Resistant Acute Leukemias. [electronic resource]
- Cancer cell 04 2019
- 664-676.e7 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
1878-3686
10.1016/j.ccell.2019.03.004 doi
Animals Antineoplastic Agents--pharmacology Asparaginase--pharmacology Cell Death--drug effects Dose-Response Relationship, Drug Drug Resistance, Neoplasm Glycogen Synthase Kinase 3 beta--antagonists & inhibitors Humans Jurkat Cells Leukemia--drug therapy Male Mice, Inbred NOD Mice, Transgenic Polyethylene Glycols--pharmacology Proteasome Endopeptidase Complex--metabolism Protein Kinase Inhibitors--pharmacology Protein Stability Proteolysis Synthetic Lethal Mutations THP-1 Cells Ubiquitination Wnt Signaling Pathway--genetics Wnt3A Protein--genetics Xenograft Model Antitumor Assays